Latest Articles
-
Reading Between The Lines Of ADI’s Latest Call
Analog Devices just posted a monster quarter, but analysts on the call wanted to know if this AI-fueled supercycle is a new reality or just a spectacular peak. After a year of strong gains for its stock, Analog Devices (ADI) just posted the firs...
-
$2.5 Billion In Payouts, A Lagging Stock: The CLF Trade-Off
This steelmaker sent a fortune back to its owners, but the stock went nowhere. Here’s the paradox of the payout, and what it means now. Cleveland-Cliffs (CLF), a cornerstone of the American steel industry, trades around $11.27 a share, well off...
-
History Has An Opinion On This SNPS Price Level
A critical piece of the AI supply chain has seen its stock slide back to a familiar floor, forcing investors to ask if history’s powerful rebound rhyme is about to repeat. Synopsys (SNPS), whose software is essential for designing the wor...
-
Eli Lilly Stock Raised Its Forecast, So Why Is The Market Shrugging?
Management is betting on a bigger year than ever, but investors seem to be waiting for a catch. When a company with a $1.12 trillion market cap tells you it expects to pull in an extra few billion dollars, you listen. On Aug 5, 2026, the company...
-
Is Meta Stock Actually the Cheapest Mega-Cap Tech Bet?
The social media giant is delivering elite-level growth and profits, yet its stock commands only a mid-tier valuation. Is the market right to be so cautious, or is this a classic mismatch? After a twelve-month slide of 26%, shares of Meta Platfo...
-
ACN Stock: Why The Discount May Not Last
At $185.28, Accenture (ACN) looks set up for roughly 44% of upside over the next three years under a moderate recovery scenario. Not a moonshot, but enough to matter if the math holds. The upside is powered primarily by steady earnings growth, wh...
-
Get Paid 12% A Year To Hold NFLX Stock You Already Own
For Netflix shareholders, here is a way to get paid a meaningful income right now, money you keep no matter what, in exchange for agreeing to sell your stock at a higher price if it climbs. Netflix (NFLX) has been a story of competing realities...
-
What You Actually Pay To Join The MU Run
A powerful run in this AI-critical stock has paused, forcing investors to decide if its world-class business engine has more fuel than the market has priced in. Micron Technology (MU) makes the memory and data storage that are the lifeblood of ...
-
After Its Recent Stumble, Is Broadcom Stock An Opportunity Or A Trap?
The chipmaker’s AI business is booming, but the stock just hit a rough patch, forcing investors to weigh a powerful history against a pricey present. At Broadcom (AVGO), the story from management is one of almost overwhelming demand. On it...
-
Uranium Energy Stock Is Priced On Pounds It Has Not Sold Yet
A sales multiple built on about $20 million of trailing revenue, a figure that rounds to zero in the billions the company reports, measures a decision rather than a business, leaving the buy case resting on what the production ramp costs per poun...
-
Marvell Technology Stock More Than Tripled On A Roadmap It Had Been Publishing All Along
The clues to the run sat in dated interconnect milestones, not in the custom-silicon question that dominated the argument surrounding the stock. Marvell Technology (MRVL) stock returned 233.5% over the past year, against 21.0% for the S&P 5...
-
Cisco Grows Into Its Multiple, And The Market Has To Do The Rest
Consensus has the earnings arriving, and the multiple falling, yet the scenario that follows leaves a holder within a few percent of today’s price unless the market goes on paying a richer forward multiple than it does today. Cisco System...
-
Arista Networks Is Buying Further Ahead Than It Can See
The company’s multiyear purchase commitments have nearly tripled in a year while its view of customer demand still reaches only two quarters out. Arista Networks (ANET) has just posted its first $3 billion quarter and lifted its 2026 reve...
-
The Shock Record Understates How Far Applied Optoelectronics Stock Can Fall
Its deepest decline across its full price history runs well past anything a catalogued market shock produced, and the next test sits inside a production ramp the company says is bounded by capacity and parts. Applied Optoelectronics (AAOI) is u...
-
Moderna Stock Had A Readout Waiting In Plain Sight
Before the melanoma result, the visible signs were an enrolled trial, a partner paying half its cost, and a market that had stopped pricing an unusually large move Moderna (MRNA) stock has multiplied over the past year, and the result that more...
